8 May, 2025HAYA Therapeutics raises $65 million in Series A funding to deliver precision RNA-guided medicines for chronic and age-related diseases
6 May, 2025BrightHeart obtains second FDA clearance for expansion of platform capabilities - adding tablet support for fetal heart ultrasound evaluations
30 April, 2025NodThera’s oral NLRP3 inhibitor NT-0796 enhances and sustains weight loss in combination with GLP-1
29 April, 2025The Phase 3 ABTECT trials in patients with moderately to severely active Ulcerative Colitis